Molecular Biosystems
This article was originally published in The Gray Sheet
Executive Summary
Cost reduction program will include laying off 33 of the company's 56 employees and discontinuing development for its MB840 liver imaging agent to save $5 mil. annually, the company announces March 30. The move follows Palatin Technologies' March 14 decision not to proceed with a planned merger between the two imaging agent developers (1"The Gray Sheet" March 20, p. 15). MBI plans to focus solely on its Optison imaging agent